GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » EV-to-Revenue

Medipal Holdings (TSE:7459) EV-to-Revenue : 0.09 (As of Apr. 30, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medipal Holdings's enterprise value is 円323,712 Mil. Medipal Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円3,507,505 Mil. Therefore, Medipal Holdings's EV-to-Revenue for today is 0.09.

The historical rank and industry rank for Medipal Holdings's EV-to-Revenue or its related term are showing as below:

TSE:7459' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.06   Med: 0.12   Max: 0.18
Current: 0.09

During the past 13 years, the highest EV-to-Revenue of Medipal Holdings was 0.18. The lowest was 0.06. And the median was 0.12.

TSE:7459's EV-to-Revenue is ranked better than
93.81% of 97 companies
in the Medical Distribution industry
Industry Median: 0.6 vs TSE:7459: 0.09

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-30), Medipal Holdings's stock price is 円2470.00. Medipal Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円16,558.30. Therefore, Medipal Holdings's PS Ratio for today is 0.15.


Medipal Holdings EV-to-Revenue Historical Data

The historical data trend for Medipal Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings EV-to-Revenue Chart

Medipal Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.10 0.11 0.09 0.09

Medipal Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.09 0.13 0.13 0.11

Competitive Comparison of Medipal Holdings's EV-to-Revenue

For the Medical Distribution subindustry, Medipal Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's EV-to-Revenue falls into.



Medipal Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medipal Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=323711.729/3507505
=0.09

Medipal Holdings's current Enterprise Value is 円323,712 Mil.
Medipal Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,507,505 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipal Holdings  (TSE:7459) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medipal Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2470.00/16558.3
=0.15

Medipal Holdings's share price for today is 円2470.00.
Medipal Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円16,558.30.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipal Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipal Holdings (TSE:7459) Business Description

Traded in Other Exchanges
Address
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines